Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × testosterone undecanoate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hypogonadism 3 Eunuchism 2 Testicular Neoplasms 1 Prostatic Neoplasms 1 Prostate Cancer Recurrent 1 Neoplasm Metastasis 1 Klinefelter Syndrome 1 Infertility 1 Fatigue Syndrome, Chronic 1 Carcinoma, Renal Cell 1

Interventions

Nivolumab 130 Sunitinib 120 pembrolizumab 116 Sorafenib 75 Everolimus 67 cabozantinib 66 Bevacizumab 66 pazopanib 60 Ipilimumab 55 Axitinib 55 aldesleukin 48 Magnetic Resonance Spectroscopy 41 Cyclophosphamide 36 Interleukin-2 33 Radiosurgery 32 Interferon-alpha 32 lenvatinib 31 Specimen Handling 29 temsirolimus 27 atezolizumab 24 belzutifan 21 fludarabine phosphate 20 Gemcitabine 20 avelumab 18 Radiotherapy 18 Interferon alpha-2 17 Biopsy 16 fludarabine 15 durvalumab 15 Paclitaxel 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03379012 2019-10-22

FARETES

Kidney Cancer Research Bureau

Phase 2 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡